Exact Mass: 173.07014220000002
Exact Mass Matches: 173.07014220000002
Found 147 metabolites which its exact mass value is equals to given mass value 173.07014220000002
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Acetyl-L-glutamate 5-semialdehyde
N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the. second to last step in the synthesis of L-Ornithine and is converted. from N-Acetyl-L-glutamate 5-phosphate via the enzyme N-acetyl-gamma-glutamyl-phosphate reductase (EC 1.2.1.38). It is then converted to N-Acetylornithine via the enzyme acetylornithine aminotransferase (EC 2.6.1.11). N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the
2-Oxoarginine
2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275 , 1588833 , 1690873 , 819629). 2-Oxoarginine has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821). 2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275, 1588833, 1690873, 819629) [HMDB]
Triethylenephosphoramide
C6H12N3OP (173.07179519999997)
D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
(1r,3r)-1-Aminocyclopentane-1,3-dicarboxylic acid
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents trans-ACPD, a metabotropic receptor agonist, produces calcium mobilization and an inward current in cultured cerebellar Purkinje neurons.
Me glycoside-alpha-D-Pyranose-4-Amino-2,3,4-trideoxy-erythro-hex-2-enuronic acid
5-(2-ETHOXY-ETHYL)-[1,3,4]THIADIAZOL-2-YLAMINE
C6H11N3OS (173.06227959999998)
2-Hydroxy-2-phenylethanaminium chloride
C8H12ClNO (173.06073719999998)
3-HYDROXYPHENETHYLAMINE HYDROCHLORIDE
C8H12ClNO (173.06073719999998)
(S)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-5-AMINE HYDROCHLORIDE
C7H12ClN3 (173.07197019999998)
(R)-3-(1-aminoethyl)phenol hydrochloride
C8H12ClNO (173.06073719999998)
2,5-dibromopiperidine
Cis-piperidine-2,3-dicarboxylic acid is a non-specific antagonist of NMDA, AMPA and kainate ionotropic receptors and a partial agonist for NMDA receptors. Cis-piperidine-2,3-dicarboxylic acid can be used in blocking general excitatory synaptic transmissions[1].
5-tert-Butyl-2-(chloromethyl)oxazole
C8H12ClNO (173.06073719999998)
4,5,6,7-Tetrahydro-2H-indazol-3-ylaMine dihydrochloride
C7H12ClN3 (173.07197019999998)
(1R,2S,6R,7S)-4,4-DIMETHYL-3,5-DIOXA-8-AZATRICYCLO[5.2.1.0(2,6)]DECAN-9-ONE
2-Amino-5-ethylphenol hydrochloride (1:1)
C8H12ClNO (173.06073719999998)
Tyramine
C8H12ClNO (173.06073719999998)
Tyramine hydrochloride is an amino acid that helps regulate blood pressure. Tyramine hydrochloride occurs naturally in the body, and it's found in certain foods[1].
Oxaceprol
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents D003879 - Dermatologic Agents D - Dermatologicals
O-(4-METHYLBENZYL)HYDROXYLAMINE HYDROCHLORIDE
C8H12ClNO (173.06073719999998)
(R)-2-TERT-BUTOXYCARBONYLAMINO-3-(2-HYDROXY-PHENYL)-PROPIONICACID
C8H12ClNO (173.06073719999998)
[2-(Aminooxy)ethyl]benzene hydrochloride (1:1)
C8H12ClNO (173.06073719999998)
N-Methyl-p-anisidine hydrochloride ,98
C8H12ClNO (173.06073719999998)
1,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine,hydrochloride
C7H12ClN3 (173.07197019999998)
2-hydroxy-n-methylbenzylamine hydrochloride
C8H12ClNO (173.06073719999998)
4-(Dimethylamino)phenol hydrochloride
C8H12ClNO (173.06073719999998)
3-(chloromethyl)-5-(2-methylpropyl)-1,2-oxazole
C8H12ClNO (173.06073719999998)
4-BUTYL-5-MERCAPTO-4H-1,2,4-TRIAZOL-3-OL
C6H11N3OS (173.06227959999998)
3-Methoxy-2-methylaniline hydrochloride
C8H12ClNO (173.06073719999998)
(4-(AMINOMETHYL)PHENYL)METHANOL HYDROCHLORIDE
C8H12ClNO (173.06073719999998)
2-Ethyl-3-hydroxy-6-methylpyridine hydrochloride
C8H12ClNO (173.06073719999998)
(2-Methoxyphenyl)methanamine hydrochloride
C8H12ClNO (173.06073719999998)
7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline
dl-b-hydroxyphenethylamine hydrochloride
C8H12ClNO (173.06073719999998)
N-pyridin-4-ylethane-1,2-diamine,hydrochloride
C7H12ClN3 (173.07197019999998)
4-Pyrimidinamine,N-ethyl-2,6-difluoro-5-methyl-(9CI)
2-Amino-1-phenylethanol hydrochloride
C8H12ClNO (173.06073719999998)
3-(4-CHLORO-3-METHYL-PYRAZOL-1-YL)-PROPYLAMINE
C7H12ClN3 (173.07197019999998)
7-BROMO-1,2,3,4-TETRAHYDROISOQUINOLINEHYDROCHLORIDE
(+/-)-1-aminocyclopentane-cis-1,2-dicarboxylic acid
1-(2-Hydroxyethyl)-5-oxopyrrolidine-3-carboxylic acid
3-(2-Pyridyl)-1-propanol Hydrochloride
C8H12ClNO (173.06073719999998)
(2S,5R)-5-(Carboxymethyl)pyrrolidine-2-carboxylic acid
(2R,5R)-5-(carboxymethyl)pyrrolidine-2-carboxylic acid
4,7-Dimethylpyrazolo[5,1-c][1,2,4]triazine-3-carbonitrile
Triethylenephosphoramide
C6H12N3OP (173.07179519999997)
D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
5-guanidino-2-oxopentanoic acid zwitterion
Zwitterionic form of 5-guanidino-2-oxopentanoic acid.
2-Acetamido-5-oxopentanoic acid
A glutamic semialdehyde that is L-glutamate 5-semialdehyde in which one of the hydrogens of the amino group has been replaced by an acetyl group.
5-Guanidino-2-oxopentanoic acid
A 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group.
(5S)-5-(carboxymethyl)-L-proline
A L-proline derivative that is L-proline substituted at position 5 by a carboxymethyl group.
α-keto-δ-guanidino-valericacid
{"Ingredient_id": "HBIN015573","Ingredient_name": "\u03b1-keto-\u03b4-guanidino-valericacid","Alias": "NA","Ingredient_formula": "C6H11N3O3","Ingredient_Smile": "C(CC(=O)C(=O)O)CN=C(N)N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12196","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}